Physician profile
William P Lorio
NPI 1194719591
$1,440.77
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $25.05 · 2021: $238 · 2022: $178 · 2023: $535 · 2024: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $351.41 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $213.77 | 2019-2023 | Otezla, Repatha |
| Lilly USA, LLC | $208.24 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $146.02 | 2021-2023 | |
| Daiichi Sankyo INC. | $121.58 | 2022-2024 | Injectafer |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.50 | 2019-2023 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $75.59 | 2019-2022 | |
| Novo Nordisk INC | $43.69 | 2020-2024 | Ozempic, Rybelsus |
| Pfizer INC. | $27.05 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $26.53 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.95 | 2021 | |
| Medtronic, INC. | $18.88 | 2022 | |
| Masimo Corporation | $15.82 | 2023 | Patient Safetynet System, Set and Rainbow Set |
| Ironwood Pharmaceuticals, INC | $15.41 | 2024 | |
| Medtronic USA, INC. | $13.17 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $13.08 | 2023 | Onpattro |
| Amarin Pharma, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.